Abstract
BackgroundAdoptive T cell therapy (ACT) utilizing ex vivo-expanded autologous tumor infiltrating lymphocytes (TILs) can result in complete regression of human cancers.1 Successful immunotherapy is influenced by several tumor-intrinsic factors.2 3...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have